| Q33975799 | Active immunization in the United States: developments over the past decade |
| Q38200971 | Clinical and molecular aspects of the live attenuated Oka varicella vaccine |
| Q39685724 | Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus |
| Q37420420 | Detection and genotyping of varicella-zoster virus by TaqMan allelic discrimination real-time PCR. |
| Q45738749 | Detection of herpes simplex virus and varicella-zoster virus in clinical swabs: frequent inhibition of PCR as determined by internal controls |
| Q34218642 | Live-attenuated varicella vaccine |
| Q43547992 | Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia |
| Q37932527 | Molecular studies of the Oka varicella vaccine |
| Q35942988 | Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zoster |
| Q34295291 | ORF7 of varicella-zoster virus is a neurotropic factor |
| Q36132147 | Presence of Vaccine-Derived Newcastle Disease Viruses in Wild Birds. |
| Q33719386 | Preventing varicella-zoster disease |
| Q33970458 | Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes |
| Q45730342 | Responses of varicella zoster virus (VZV)-specific immunity in seropositive adults after inhalation of inactivated or live attenuated varicella vaccine |
| Q38245786 | Shingles vaccination: background and advice for community nurses. |
| Q33900399 | The varicella-zoster virus portal protein is essential for cleavage and packaging of viral DNA. |
| Q93022477 | Transmission of Vaccine-Strain Varicella-Zoster Virus: A Systematic Review |
| Q45761229 | Transmission of varicella-vaccine virus from a healthy 12-month-old child to his pregnant mother |
| Q36507660 | Vaccination in the primary care setting: when is it safe to proceed? |
| Q37738787 | Vaccine-related varicella-zoster rash in a hospitalized immunocompetent patient |
| Q40278402 | Varicella |
| Q44257740 | Varicella vaccination of health-care workers |
| Q34315355 | Varicella vaccination--a critical review of the evidence |
| Q40634099 | Varicella vaccine in non-immune household contacts of children with cancer or leukaemia |
| Q36066227 | Varicella-zoster vaccine in the USA: success for control of disease severity, but what next? |
| Q36006384 | Varicella-zoster virus glycoproteins B and E are major targets of CD4+ and CD8+ T cells reconstituting during zoster after allogeneic transplantation |
| Q36861648 | Zoster vaccine live |